Doctors from NYU Langone Medical Center: Langone This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.


Abstract:
Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection. As a result of in vitro evidence suggesting zinc sulfate may be efficacious against COVID-19, our hospitals began using zinc sulfate as add-on therapy to hydroxychloroquine and azithromycin. We performed a retrospective observational study to compare hospital outcomes among patients who received hydroxychloroquine and azithromycin plus zinc versus hydroxychloroquine and azithromycin alone. Methods: Data was collected from electronic medical records for all patients being treated with admission dates ranging from March 2, 2020 through April 5, 2020. Initial clinical characteristics on presentation, medications given during the hospitalization, and hospital outcomes were recorded. Patients in the study were excluded if they were treated with other investigational medications. Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.

Source:
https://www.researchgate.net/publication/341254876_Hydroxychloroquine_and_azithromycin_plus_zinc_vs_hydroxychloroquine_and_azithromycin_alone_outcomes_in_hospitalized_COVID-19_patients

Popular Posts in the Last 7 Days

Why Brigitte Huber may be the most important AIDS and Chronic Fatigue Syndrome researcher

Perplexity writes a fantasy Joe Rogan interview with Rebecca Culshaw

Perplexity on the implications of Rebecca Culshaw Smith's critique of HIV

Twenty Potential Mistakes Leading to the Misidentification of HIV as the Cause of AIDS

Perplexity A.I. on the potential consequences of Rebecca Culshaw's Critique of HIV

Popular Post in the Last 30 Days

Why Brigitte Huber may be the most important AIDS and Chronic Fatigue Syndrome researcher

If the establishment decides that the nosology of AIDS is wrong and HIV is not the cause of AIDS could that be considered a Black Swan event?

Has Maureen Hanson found another opportunistic infection that links Chronic Fatigue Syndrome and AIDS?

A new cartoon

Time for action on HHV-6! Please post and circulate:

Popular Posts from the Last Year

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Why HIV should be referred to as "a red herring."

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Dr. Rebecca Culshaw Smith's book is discussed on Twitter

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?